Cargando…

Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System

Background: Determining the need for prostate biopsy is frequently difficult and more objective criteria are needed to predict the presence of high grade prostate cancer (PCa). To reduce the rate of unnecessary biopsies, we explored the potential of using biomarkers in urine and plasma to develop a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albitar, Maher, Ma, Wanlong, Lund, Lars, Albitar, Ferras, Diep, Kevin, Fritsche, Herbert A., Shore, Neal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747884/ https://www.ncbi.nlm.nih.gov/pubmed/26918043 http://dx.doi.org/10.7150/jca.12771

Ejemplares similares

Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer
por: Albitar, Ferras, et al.
Publicado: (2015)

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy
por: Albitar, Maher, et al.
Publicado: (2017)

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
por: Albitar, Adam, et al.
Publicado: (2017)

Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations
por: Lee, Tai-Sung, et al.
Publicado: (2009)

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
por: Ma, Wanlong, et al.
Publicado: (2017)

Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling
por: Lee, Tai-Sung, et al.
Publicado: (2011)

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors
por: Albitar, Maher, et al.
Publicado: (2023)

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer
por: Albitar, Maher, et al.
Publicado: (2018)

Evaluation of diagnostic parameters in detecting prediabetes in a cohort of Syrian healthcare providers and staff: correlations with risk factors
por: Albitar, Lina
Publicado: (2022)

An expanded biomarker panel for the detection of prostate cancer from urine DNA
por: Brikun, Igor, et al.
Publicado: (2019)

Rare isolated primary peritoneal hydatid cysts: A case report from Syria
por: Almasri, Bashar, et al.
Publicado: (2017)

Assessment of attitudes and practices towards COVID-19 pandemic: a survey on a cohort of educated Syrian population
por: Albitar, Lina, et al.
Publicado: (2023)

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
por: Ma, Wanlong, et al.
Publicado: (2010)

Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM
por: Albitar, A, et al.
Publicado: (2018)

Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
por: Alijaj, Nagjie, et al.
Publicado: (2022)

Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data
por: Albitar, Maher, et al.
Publicado: (2023)

Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
por: Albitar, Lina, et al.
Publicado: (2021)

Cholera in Syria, a crisis following crises: Assessment of knowledge, attitude, and practice in a cohort of syrian population
por: Albitar, Lina, et al.
Publicado: (2023)

Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine
por: Lima, Ana Rita, et al.
Publicado: (2019)

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
por: Lee, Bongyong, et al.
Publicado: (2020)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
por: Moreira-Barbosa, Catarina, et al.
Publicado: (2018)

Plasma Polyamine Biomarker Panels: Agmatine in Support of Prostate Cancer Diagnosis
por: Coradduzza, Donatella, et al.
Publicado: (2022)

A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies
por: Batenchuk, Cory, et al.
Publicado: (2018)

Prostate cancer marker panel with single cell sensitivity in urine
por: Nickens, Kristen P., et al.
Publicado: (2015)

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
por: Johnson, Heather, et al.
Publicado: (2020)

A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer
por: Matin, Farhana, et al.
Publicado: (2018)

Artificial Intelligence (AI) for Detection and Localization of Unobturated Second Mesial Buccal (MB2) Canals in Cone-Beam Computed Tomography (CBCT)
por: Albitar, Lina, et al.
Publicado: (2022)

Association of autosomal dominant polycystic kidney disease, asymptomatic multiple giant coronary arteries aneurysms and abdominal aortic aneurysm: a case report
por: Hindawy, Abdullah Rida, et al.
Publicado: (2020)

Predicting PD-L1 Status in Solid Tumors Using Transcriptomic Data and Artificial Intelligence Algorithms
por: Charifa, Ahmad, et al.
Publicado: (2024)

Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome
por: Ma, Wanlong, et al.
Publicado: (2010)

Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab
por: Albitar, Hasan Ahmad, et al.
Publicado: (2020)

A rare synchronous of dual primary genitourinary carcinoma manifested with a rapidly progressive renal failure
por: Affas, Athar, et al.
Publicado: (2023)

The Present and Future of Prostate Cancer Urine Biomarkers
por: Rigau, Marina, et al.
Publicado: (2013)

Risk factors for mortality among COVID-19 patients
por: Albitar, Orwa, et al.
Publicado: (2020)

The outbreak of monkeypox 2022: An overview
por: Hraib, Munawar, et al.
Publicado: (2022)

Malaria and an Amoebic Abscess in a Returning Traveler from Liberia
por: Albitar, Mhd Mustafa, et al.
Publicado: (2023)

Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy
por: Örtegren, Joakim, et al.
Publicado: (2022)

A predictive biomarker panel for bone metastases: Liquid biopsy approach
por: Bhadresha, Kinjal P., et al.
Publicado: (2021)

Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System
por: Gonçalves, Micael F. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dum96t7ohh6304l01i51hdbuib